Details
- Status
- Open
- Reference
- HORIZON-MISS-2024-CANCER-01-04
- Publication date
- 18 April 2024
- Opening date
- Deadline model
- Single-stage
- Deadline date
- 18 September 2024, 17:00 (CEST)
- Programme Sector
- Health
- Programme
- Horizon Europe Cluster 1: Health
- Tags
- Medical research
- Public health
Description
To support the objective of the EU Mission on Cancer to optimise cancer diagnostics and treatments, the Commission envisages an action to facilitate coordination among charities and other relevant stakeholders for the establishment and implementation of a funding programme for pragmatic clinical trials.
HaDEA has published the call HORIZON-MISS-2024-CANCER-01, comprising six topics.
Topic 04 is HORIZON-MISS-2024-CANCER-01-04: Support a pragmatic clinical trial programme by cancer charities (CSA).
The successful proposal under this topic should aim to deliver results that are directed and tailored towards and contribute to all of the following expected outcomes:
- Together, a network of registered cancer charities and foundations support multi-centre, transnational pragmatic clinical trials on cancers with a 5-year overall survival less than 50% from time of diagnosis or rare cancers using their own resources.
- Cancer patients and their caregivers have access to more effective and patient-centred, treatment and care solutions.
- Researchers, innovators, and professionals from different disciplines and sectors ensure accessibility and re-usability of relevant trial data, to support the UNCAN.eu research data platform, which is currently in preparation.
- National healthcare providers, policymakers and authorities in European regions, Member States and Associated Countries have the evidence to implement affordable and accessible treatment and care solutions in their healthcare systems.